ライフサイエンスコーパス: residual volume

1 e thus resulting in a marked increase in the residual volume.

2 expiration from near total lung capacity to residual volume.

3 r lung assessment at total lung capacity and residual volume.

4 /- 0.4 L), functional residual capacity, and residual volume.

5 ssess patients with suspected large postvoid residual volumes.

6 ificantly fewer episodes of elevated gastric residual volumes (2% vs. 8% of feeding days; p < .001).

7 derived mean lung capacity decreased 13% and residual volume 20% (p < 0.00001 for each), while mean t

8 ction tests were (%predicted): FEV(1) = 27%; residual volume = 224.6%; diffusion capacity = 26.7%.

9 cond, 33+/-4 percent of the predicted value; residual volume, 259+/-25 percent of the predicted value

10 ent feeding days; P = .05), elevated gastric residual volumes (4.9% vs 2.2% of feeding days; P < .001

11 hange in total lung capacity -16%; change in residual volume -55%) in a pattern that resulted in sign

12 Changes in FEV1, residual volume, 6-minute-walk distance, St. George's Re

13 +/- 15.20 vs. 7.55 +/- 14.88%; P < 0.0001), residual volume (-66.20 +/- 40.26 vs. -47.06 +/- 39.87%;

14 change in total lung capacity +8%; change in residual volume +66%), reduced DL(CO) (-21%), and elevat

15 and clinically significant: DeltaEBV-SoC for residual volume, -700 ml; 6-minute-walk distance, +78.7

16 greater LV mass (7.2 g per 1-SD increase in residual volume; 95% confidence interval, 2.2-12; P=0.00

17 nce interval, -0.52 to 1.38), prostate size, residual volume after voiding, quality of life, or serum

18 There was no detectable difference in residual volume among treatment groups, but the diminish

19 changes in lung function, such as increased residual volume and decreased flow; these increases in a

20 on states), initial bladder contents volume, residual volume and first void time.

21 bjects, resulted in significant increases in residual volume and pressure-volume hysteresis, suggesti

22 75% of vital capacity, and the ratio between residual volume and total lung capacity were significant

23 ilated patients with mildly elevated gastric residual volumes and already receiving nasogastric nutri

24 ures, such as expanding bladder contents and residual volume, and variable urinary input rate, initia

25 al air trapping in prepubertal girls because residual volumes are not detected on standard spirometri

26 h hypertonic saline and placebo, whereas the residual volume as a proportion of total lung capacity (

27 recoil led to disproportionate decreases in residual volume as compared with total lung capacity (16

28 The Rp positively correlated with the residual volume at both 4:00 P.M. (r = 0.71, p = 0.004)

29 eeks) and include only men with low postvoid residual volumes at baseline, and the results are, there

30 eased forced expiratory volume and increased residual volume compared with patients with severe asthm

31 rence between TLC total lung capacity and RV residual volume correlated positively with (3)He signal

32 , prostate volume decreased by 20%, postvoid residual volume decreased by 30 mL, and IIEF score incre

33 increased by 390+/-570 ml (P<0.001), and the residual volume decreased by 439+/-493 ml (P=0.02), as c

34 adders and kidneys; however, the severity of residual volumes does not predict increased susceptibili

35 , actual volume delivered, patient position, residual volume, flush volume, presence of blue food col

36 78 antibody-positive animals had sufficient residual volume for detection of HEV RNA (viremia) by re

37 w fraction [OF], venous filling index [VFI], residual volume fraction [RVF]) and venous duplex, tread

38 t at four lung volumes (residual volume [ RV residual volume ], functional residual capacity [ FRC fu

39 lume group), in contrast to the high gastric residual volume group (n = 9).

40 idual volume higher than 250 mL (low gastric residual volume group), in contrast to the high gastric

41 patients or between the high and low gastric residual volume groups.

42 yperinflation (total lung capacity >100% and residual volume >150%), a restricted exercise capacity (

43 In fed patients, 13 never had a gastric residual volume higher than 250 mL (low gastric residual

44 uspended functional residual capacity and at residual volume in two lung regions (above and below the

45 Mean residual volumes in the SCI animals did not correlate wi

46 ife (QOL) score, peak urinary flow, postvoid residual volume, International Index Erectile Function (

47 irus (Jc1/GLuc2A) to simulate 2 scenarios of residual volumes: low void volume (2 microL) for 1-mL in

48 nclude tests such as uroflowmetry, post-void residual volume measurement, renal ultrasound, (video-)u

49 ved to be in the supine position only 0.45%, residual volume of >200 mL was found 2.8%, and blue food

50 Residual volumes of nutrition in the small bowel were <

51 ution was not associated with larger gastric residual volumes or diarrhea.

52 ume in one second (FEV1) (P=0.004), a higher residual volume (P=0.007), a lower ratio of FEV1 to forc

53 l lung capacity % predicted (p=0.05), higher residual volume % predicted (p=0.04), lower maximal card

54 an +/- SD]; FEV1, % predicted, 29.3 +/- 6.5; residual volume, % predicted, 275.4 +/- 59.4) were alloc

55 ary bother, nocturia, peak uroflow, postvoid residual volume, prostate-specific antigen level, partic

56 /- 1.3 versus 7.65 +/- 2.1 L, p < 0.001) and residual volume (RV) (3.7 +/- 1.2 versus 4.9 +/- 1.1 L,

57 ity (FVC), pre- and postbronchodilator FEV1, residual volume (RV), and total lung capacity (TLC) were

58 Hyperinflation was present at residual volume (RV), FRC, and TLC in all subjects.

59 expression on patrolling monocytes predicted residual volume (RV), RV/TLC ratio, and FRC, after adjus

60 al capacity (FRC) and almost all the lung at residual volume (RV).

61 significant and similar decreases in TLC and residual volume (RV).

62 as inflated to 80% TLC, and then deflated to residual volume (RV).

63 ollowing the surgically induced reduction in residual volume (RV).

64 treatment group (n = 50) spirometric, Feno, residual volume (RV)/total lung capacity (TLC), AHR, and

65 Elevated residual volumes (RV), considered a marker for the risk

66 5-T whole-body MR unit at four lung volumes (residual volume [ RV residual volume ], functional resid

67 1.0 +/- 4.5% predicted), and hyperinflation (residual volume [RV] 341.8 +/- 75.8% predicted).

68 ents who had severe hyperinflation (ratio of residual volume [RV] to total lung capacity of >/=0.65).

69 g (FEV1, 0.73 +/- 0.2 L; TLC, 7.3 +/- 1.6 L; residual volume [RV], 4.8 +/- 1.4 L), and moderate resti

70 A postvoid residual volume should be measured prior to commencing a

71 ; 95% confidence interval [CI]: 0.21, 0.91), residual volume (static hyperinflation, r = -0.8; 95% CI

72 cantly reduced bladder capacity and postvoid residual volume than diabetic rats injected with the con

73 ng capacity (TLC) (P = 0.02) and % predicted residual volume/TLC (P = 0.05).

74 Sixty-nine bottles had sufficient residual volume to conduct HPLC analysis.

75 ith a corresponding increase in the ratio of residual volume to micturition volume.

76 rway obstruction as assessed by the ratio of residual volume to total lung capacity (RV/ TLC) (r = 0.

77 = 0.48, P <.005), percent predicted ratio of residual volume to total lung capacity (RV/TLC%) (r = -0

78 ion common to these diseases is the ratio of residual volume to total lung capacity (RV/TLC).

79 C, inspiratory lung resistance, and ratio of residual volume to total lung capacity postalbuterol pre

80 (P=0.02) and with hyperinflation measured as residual volume to total lung capacity ratio (P=0.009).

81 by days 14 and 21 (P=.02); and the ratio of residual volume to total lung capacity, a measure of tho

82 arbon monoxide (beta = 0.60, P = .0008), and residual volume/total lung capacity (beta = -0.26, P = .

83 HI was defined as either a residual volume/total lung capacity (RV/TLC) above the u

84 Residual volume/total lung capacity (RV/TLC) ratio decre

85 % predicted VCmax (P = 0.05), and decreasing residual volume/total lung capacity (TLC) (P = 0.02) and

86 VRS led to a relative reduction in mean (SD) residual volume/total lung capacity of -12% (12%) and an

87 w limitation (FEV1/forced vital capacity and residual volume/total lung capacity ratios) and greater

88 Hyperinflation was defined as residual volume/total lung capacity.

89 6+/-712 ml above the baseline value, and the residual volume was 333+/-570 ml below the baseline valu

90 An increase in residual volume was noted in one heterozygous family mem

91 Residual volume was unexpectedly reduced by 18% in micro

92 analyzing a solvent aliquot evaporated to 1% residual volume, while the other four nulls were properl

93 trials demonstrated an increase in postvoid residual volume with anticholinergic therapy.

94 index and a 429 ml (P < 0.001) reduction in residual volume with fluticasone furoate/vilanterol vers